Chemomab Therapeutics Ltd ADR (CMMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CMMB | AZN | AMGN | GILD | BMY |
| Company | Chemomab Therapeutics Ltd ADR | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 1.7700 | 183.79 | 332.99 | 131.01 | 56.18 |
| High | 1.8050 | 185.78 | 334.19 | 134.66 | 56.48 |
| Low | 1.7700 | 183.79 | 331.01 | 130.98 | 56.03 |
| Latest | 1.8050 | 185.04 | 331.37 | 133.88 | 56.03 |
| Change | +0.0350 | +2.19 | -0.33 | +2.55 | -0.13 |
| % Change | +1.98% | +1.20% | -0.10% | +1.94% | -0.23% |
| Volume | 2,057 | 423,623 | 166,923 | 820,485 | 789,045 |
| 20-Day Average Volume | 37,763 | 2,012,518 | 2,548,558 | 5,825,529 | 9,750,865 |
| Previous Close | 1.7700 | 182.85 | 331.70 | 131.33 | 56.16 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.6431 | 190.82 | 340.50 | 133.64 | 58.11 |
| 20-Day Raw Stochastic | 84.62% | 22.77% | 33.67% | 47.27% | 14.97% |
| 20-Day Relative Strength | 55.57 | 43.61 | 42.47 | 47.20 | 43.37 |
| Weighted Alpha | -63.22 | +28.28 | +17.14 | +25.73 | +20.09 |
| Today's Opinion | 24% Sell | 8% Sell | 8% Sell | 24% Buy | 24% Buy |
| Previous Opinion | 24% Sell | 8% Sell | 8% Sell | 8% Sell | 24% Buy |
| Last Month's Opinion | 88% Sell | 88% Buy | 40% Buy | 40% Buy | 48% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +9.88% since 05/04/26 | +1.25% since 05/04/26 | +2.75% since 05/04/26 | +1.10% since 05/04/26 | -1.80% since 05/04/26 |
| Low | 1.6000 on 05/05/26 | 180.00 on 05/05/26 | 320.52 on 05/05/26 | 129.00 on 05/08/26 | 55.57 on 05/07/26 |
| High | 1.8400 on 05/07/26 | 185.76 on 05/11/26 | 333.73 on 05/11/26 | 136.75 on 05/06/26 | 57.48 on 05/05/26 |
| 1-Month | |||||
| %Chg | +6.59% since 04/10/26 | -8.95% since 04/10/26 | -5.20% since 04/10/26 | -3.49% since 04/10/26 | -3.87% since 04/10/26 |
| Low | 1.4500 on 04/29/26 | 180.00 on 05/05/26 | 320.52 on 05/05/26 | 127.64 on 04/27/26 | 55.57 on 05/07/26 |
| High | 1.8400 on 05/07/26 | 205.30 on 04/17/26 | 356.90 on 04/20/26 | 141.40 on 04/14/26 | 60.78 on 04/30/26 |
| 3-Month | |||||
| %Chg | +12.66% since 02/11/26 | -9.28% since 02/11/26 | -9.22% since 02/11/26 | -13.90% since 02/11/26 | -5.97% since 02/11/26 |
| Low | 1.3500 on 02/25/26 | 180.00 on 05/05/26 | 320.52 on 05/05/26 | 127.64 on 04/27/26 | 55.57 on 05/07/26 |
| High | 2.2359 on 03/17/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 156.95 on 02/13/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | -33.33% since 11/11/25 | +4.25% since 11/11/25 | -1.68% since 11/11/25 | +9.45% since 11/11/25 | +15.66% since 11/11/25 |
| Low | 1.3500 on 02/25/26 | 174.46 on 11/12/25 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 45.26 on 11/20/25 |
| High | 2.8492 on 11/18/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 12,730 | 283,583,520 | 179,013,520 | 163,009,696 | 114,682,712 |
| Shares Outstanding, K | 7,192 | 1,550,908 | 539,685 | 1,241,222 | 2,042,071 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -9,000,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 0 | 15,288,000,000 | 8,618,000,000 | 7,925,000,000 | 11,489,000,000 |
| Last Quarter Net Income | -1,870,000 | 3,080,000,000 | 1,819,000,000 | 2,183,000,000 | 2,677,000,000 |
| 60-Month Beta | 0.51 | 0.26 | 0.44 | 0.31 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.24 on 03/19/26 | 2.58 on 04/29/26 | 5.15 on 04/30/26 | 2.03 on 05/07/26 | 1.58 on 04/30/26 |
| Earnings Date | 05/21/26 | 08/04/26 | 08/04/26 | 08/06/26 | 07/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 06/15/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.71 | 14.89 | 16.02 | 9.49 |